MarketsandMarkets: Global Bio-Implants Market Worth $134.3 Billion by 2017
DALLAS, September 6, 2012 /PRNewswire/ –
The “Bio-Implants Market (Cardiovascular, Orthopaedics, Neurostimulation, Xenografts,
Allografts and Others) Competitive Analysis and Global Forecast to 2017″ published by
MarketsandMarkets (http://www.marketsandmarkets.com), analyzes and studies the major
market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of
Browse 83 tables spread through 195 pages and in-depth TOC on “Bio-Implants Market
(Cardiovascular, Orthopaedics, Neurostimulation, Xenografts, Allografts and Others)
Competitive Analysis and Global Forecast to 2017″.
Early buyers will receive 10% customization on reports.
This report studies the global bio-implants market with forecast from 2012 to 2017.
Bio-implants are defined as bioengineered products, employed in tissues or in human
living cells with the assistance of active agents or synthetic constructs used to
reproduce certain physiological functions or to treat the cause of the disease. The
bio-implants market has brought about a paradigm shift in the medical device industry with
more demand for biological implants in cardiology, vascular therapy, orthopaedics, trauma,
spine, dental, and wound care divisions. Certain bioactive implants such as drug eluting
stents, hormonal implants, and implantable drug pumps also form part of this market.
The global bio-implants market was valued at $94.1 billion in the year 2012; North
America was the largest market, followed by Europe, and Asia. The U.S. market is expected
to face a slump in the coming years due to austerity measures taken by the Federal
Government and rise in taxation caused due to the economic crisis of 2008. Uncertainty
also prevails in the European region with the Euro crisis; hence, growth is expected to be
minimal in this region for the next five years. Asia, however, will showcase higher growth
mainly due to large investments from foreign firms and government funding.
The major players in bio-implants market
[http://www.marketsandmarkets.com/Market-Reports/bio-implants-market-728.html ] are Stryker
Corporation (U.S.), Synthes (U.S.), Boston Scientific Corporation (U.S.), Biomet, Inc.
(U.S.), Smith and Nephew (U.K.), Medtronic (U.S.), St. Jude Medical, Inc. (U.S.), and
Tornier N.V. (The Netherlands).
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also
provides multi-client reports, company profiles, databases, and custom research services.
MarketsandMarkets covers thirteen industry verticals; including advanced materials,
automotives and transportation, banking and financial services, biotechnology, chemicals,
consumer goods, energy and power, food and beverages, industrial automation, medical
devices [ http://www.marketsandmarkets.com/medical-device-market-research-11.html ],
pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository. To know more about us and
our reports, please visit our website http://www.marketsandmarkets.com.
Contact: Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: email@example.com MarketsandMarkets Blog @ http://www.marketsandmarkets.blogspot.in http://twitter.com/marketsmarkets